Zuomei Li
University of Fort Lauderdale(US)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Peptidase Inhibition and Analysis, PARP inhibition in cancer therapy
Most-Cited Works
- → Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals(1998)427 cited
- → Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation(1998)401 cited
- → MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo(2008)335 cited
- → Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia(2008)234 cited
- → Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial(2011)191 cited
- → Phosphatidylinositol 3-kinase-γ activates Bruton’s tyrosine kinase in concert with Src family kinases(1997)187 cited
- → Btk function in B cell development and response(1998)183 cited
- → Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and Selectivity(2007)163 cited
- → Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors(2008)118 cited
- → Discovery of N-(2-Aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an Orally Active Histone Deacetylase Inhibitor(2008)108 cited